Related Experiment Videos
Acetaminophen and hepatic dysfunction in infectious mononucleosis
Southern Medical Journal
|June 1, 1977
Abstract:
Two family members developed severe hepatitic dysfunction in association with infectious mononucleosis and acetaminophen administration. Since severe hepatitis is an extremely rare complication of infectious mononucleosis, we postulate that the hepatic dysfunction was induced by acetaminophen.
Insights
Severe hepatitis is rare in infectious mononucleosis. This case suggests acetaminophen may cause liver dysfunction in patients with this viral illness, highlighting potential drug-induced liver injury.
Area of Science:
- Hepatology
- Virology
- Clinical Toxicology
Background:
- Infectious mononucleosis, a common viral illness, is rarely associated with severe liver injury.
- Acetaminophen (paracetamol) is a widely used over-the-counter analgesic and antipyretic.
- Drug-induced liver injury (DILI) is a significant concern in clinical practice.
Observation:
- Two family members presented with severe hepatitic dysfunction.
- Both individuals had concurrent infectious mononucleosis.
- Acetaminophen administration was noted in both cases.
Findings:
- The severe hepatitis observed is an uncommon complication of infectious mononucleosis.
- The clinical presentation suggests acetaminophen as the likely causative agent for the hepatic dysfunction.
- This case highlights a potential interaction between acetaminophen and infectious mononucleosis leading to severe liver injury.
Implications:
- Clinicians should consider acetaminophen toxicity in patients with infectious mononucleosis presenting with liver dysfunction.
- Further investigation into the potential synergistic hepatotoxicity of acetaminophen and Epstein-Barr virus infection is warranted.
- This finding underscores the importance of careful medication review in patients with viral illnesses.